A non-toxic recombinant protein rSUMO-CPBm4 as a potential vaccine candidate against Clostridium perfringens type C beta enterotoxemia

Trop Biomed. 2023 Dec 1;40(4):400-405. doi: 10.47665/tb.40.4.004.

Abstract

Beta toxin (CPB) is a lethal toxin and plays a key role in enterotoxemia of ruminants caused by Clostridium perfringens type C strain. The existing vaccines based on crude CPB need time-consuming detoxification and difficult quality control steps. In this study, we synthesized the rCPBm4 of C. perfringens type C strain and small ubiquitin-like modifier (SUMO)-tag CPBm4 (rSUMO-CPBm4) by introducing four amino acid substitutions: R212E, Y266A, L268G, and W275A. Compared with rCPBm4, rSUMO-CPBm4 was expressed with higher solubility in Escherichia coli BL21 (DE3). Neither rCPBm4 nor rSUMO-CPBm4 was lethal to mice. Although rCPBm4 and rSUMO-CPBm4 were reactogenic with polyclonal antibodies against crude CPB, rabbits vaccinated with rSUMO-CPBm4 developed significant levels of toxin-neutralizing antibody (TNA) titers that conferred protection against crude toxin challenge. These data suggest that genetically detoxified rSUMO-CPBm4 is a promising subunit vaccine candidate for C. perfringens type C beta enterotoxemia.

MeSH terms

  • Animals
  • Bacterial Toxins* / genetics
  • Bacterial Vaccines
  • Clostridium Infections* / prevention & control
  • Clostridium Infections* / veterinary
  • Clostridium perfringens / genetics
  • Enterotoxemia / prevention & control
  • Mice
  • Rabbits
  • Recombinant Proteins / genetics

Substances

  • Bacterial Toxins
  • Bacterial Vaccines
  • Recombinant Proteins